Leptomeningeal disease (LMD) occurs in less than 5% of breast cancer patients. Rarely, patients present with LMD at diagnosis. We report a case of a 59-year-old female who presented with lower back pain, radicular neuropathy with lower extremity weakness, and was found to have diffuse LMD. Workup was initiated to evaluate the etiology of LMD and later involved iliac bone biopsy showed metastatic adenocarcinoma consistent with breast carcinoma. Patient received radiation therapy followed by abemaciclib with letrozole and responded well with the treatment
Leptomeningeal dissemination due to HER2-overexpressing breast cancer is a rare and hard to treat co...
We present a case of a 57-year-old female diagnosed with invasive ductal breast cancer, which was tr...
Purpose: Leptomeningeal carcinomatosis occurs in about 5% of patients with solid tumor and is being ...
Introduction. Leptomeningeal carcinomatosis (LC) is a serious complication occuring in solid canc...
Leptomeningeal disease (LMD) or carcinomatous meningi-tis is a known entity that occurs in a small p...
Leptomeningeal disease, also known as leptomeningeal carcinomatosis, occurs when cancer metastasizes...
Malignant melanoma, breast cancer and lung cancer are the most causative malignancies of leptomening...
Leptomeningeal carcinomatosis is a serious complication of advanced cancer. Various clinical manifes...
Leptomeningeal carcinomatosis (LC) is a rare but challenging manifestation of advanced breast cancer...
Leptomeningeal metastasis (LMM), also referred to as leptomeningeal carcinomatosis, results from dif...
Leptomeningeal disease (LMD) can occur in a small percentage of patients with active metastatic canc...
BACKGROUND: Leptomeningeal metastases are diagnosed in 1% to 8% of patients with cancer. The most co...
Background: Leptomeningeal metastases are diagnosed in 1% to 8% of patients with cancer. The most co...
Purpose Leptomeningeal disease (LMD) is an uncommon complication of advanced breast cancer. The prog...
Leptomeningeal carcinomatosis is a devastating condition with very poor prognosis. With advances in ...
Leptomeningeal dissemination due to HER2-overexpressing breast cancer is a rare and hard to treat co...
We present a case of a 57-year-old female diagnosed with invasive ductal breast cancer, which was tr...
Purpose: Leptomeningeal carcinomatosis occurs in about 5% of patients with solid tumor and is being ...
Introduction. Leptomeningeal carcinomatosis (LC) is a serious complication occuring in solid canc...
Leptomeningeal disease (LMD) or carcinomatous meningi-tis is a known entity that occurs in a small p...
Leptomeningeal disease, also known as leptomeningeal carcinomatosis, occurs when cancer metastasizes...
Malignant melanoma, breast cancer and lung cancer are the most causative malignancies of leptomening...
Leptomeningeal carcinomatosis is a serious complication of advanced cancer. Various clinical manifes...
Leptomeningeal carcinomatosis (LC) is a rare but challenging manifestation of advanced breast cancer...
Leptomeningeal metastasis (LMM), also referred to as leptomeningeal carcinomatosis, results from dif...
Leptomeningeal disease (LMD) can occur in a small percentage of patients with active metastatic canc...
BACKGROUND: Leptomeningeal metastases are diagnosed in 1% to 8% of patients with cancer. The most co...
Background: Leptomeningeal metastases are diagnosed in 1% to 8% of patients with cancer. The most co...
Purpose Leptomeningeal disease (LMD) is an uncommon complication of advanced breast cancer. The prog...
Leptomeningeal carcinomatosis is a devastating condition with very poor prognosis. With advances in ...
Leptomeningeal dissemination due to HER2-overexpressing breast cancer is a rare and hard to treat co...
We present a case of a 57-year-old female diagnosed with invasive ductal breast cancer, which was tr...
Purpose: Leptomeningeal carcinomatosis occurs in about 5% of patients with solid tumor and is being ...